Reenav Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 26-06-2024
- Paid Up Capital ₹ 1.00 M
as on 26-06-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -28.24%
(FY 2023)
- Profit -13.09%
(FY 2023)
- Ebitda -18.38%
(FY 2023)
- Net Worth 48.47%
(FY 2023)
- Total Assets -24.88%
(FY 2023)
About Reenav Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kalpana Srinivasan, Anand Iyer, Rajeshree Gor, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC308208
- Company No.
308208
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2018
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Reenav Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeshree Gor  | Director | 18-Apr-2018 | Current |
| Arvind Varia | Director | 18-Apr-2018 | Current |
| Kalpana Srinivasan | Director | 04-Mar-2022 | Current |
| Anand Iyer | Director | 24-Jan-2022 | Current |
Financial Performance and Corporate Structure Insights of Reenav Pharma.
Reenav Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.24% decrease. The company also saw a substantial fall in profitability, with a 13.09% decrease in profit. The company's net worth Soared by an impressive increase of 48.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reenav Pharma?
In 2023, Reenav Pharma had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mahaveer Medi-Sales Private LimitedActive 8 years 9 monthsKalpana Srinivasan and Anand Iyer are mutual person
Vardhman Health Specialities Private LimitedActive 27 years 9 monthsKalpana Srinivasan is a mutual person
Eastern Agencies Healthcare Private LimitedActive 11 years 3 monthsKalpana Srinivasan is a mutual person
Ascent Wellness And Pharma Solutions Private LimitedActive 5 years 6 monthsKalpana Srinivasan is a mutual person
Sun Shree Multi Professional Services Ll PActive 13 years 9 monthsKalpana Srinivasan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Reenav Pharma?
Unlock and access historical data on people associated with Reenav Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reenav Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reenav Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
